Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02126683Unknown
Randomised, open-label trial of hydroxychloroquine in Hashimoto's thyroiditis (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Change of thyroid auto-antibodies at 18 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02126683.